CompaniesOxford Vacmedix
Oxford Vacmedix logo

Oxford Vacmedix

active
Oxford, UK
Founded 2012
Website
About

Cancer Vaccines

Areas of Focus

Categories

Vaccine
Team (12)
Debra Nevin PhD (Amethyst Pharma Ltd)
Manufacturing
Oxford Vacmedix
team_member
Dr Thomas Morris
Dr Thomas Morris
Chief Medical Officer
Oxford Vacmedix
executive
Laura Lugo (DLRC Ltd)
Regulatory
Oxford Vacmedix
team_member
Lisa Mynheer
Technical Support Manager
Oxford Vacmedix
team_member
Mark Thomas (FGK Clinicology Ltd)
Head of Clinical Operations
Oxford Vacmedix
team_member
Nicola Burgess-Brown
Head, Structural Genomics Consortium University of Oxford
Oxford Vacmedix
team_member
View all 12 team members →
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

36

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT05104515
Hover over trial bars to see details

Recent Trials

NCT05104515Lead Sponsor
First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
PHASE1Recruiting
36 participants
Started: Nov 1, 2021 · Completed: Jan 31, 2026
Locations (1)
Headquarters
Oxford, UK
Map

Loading map...